|Aceras Life Sciences||-|
|AOI Holdings||Chiyoda, Japan|
|Bangladesh Angels||Bangladesh, Dhaka, Dhaka Division|
|Bank of England||England, London, United Kingdom|
|Bluehawk Capital||Australia, Melbourne, Victoria|
|Carnrite Ventures||Houston, Texas, United States|
|Concurrence Capital Holdings||Grand Rapids, Michigan, United States|
|HMS Hawaii Management||Hawaii, Honolulu, United States|
|Kairos||New York, New York, United States|
|kubota||Japan, Osaka, Osaka Prefecture|
|Medina Capital||Coral Gables, Florida, United States|
|SLOGAN COENT LLP||Chiyoda, Japan|
|Squirrel Hill Ventures||Mineola, New York, United States|
|Telecom Partners||New York, New York, United States|
|Tensor Ventures||Czech Republic, Prague, Prague|
|W Ventures||Dortmund, Germany, Nordrhein-Westfalen|
|$10M||01 May 2014||Kfar Saba, HaMerkaz, Israel|
|$15M||01 Sep 2013||Kfar Saba, HaMerkaz, Israel|
|$16M||12 Jul 2011||Kfar Saba, HaMerkaz, Israel|
|$28M||20 Feb 2008||Kfar Saba, HaMerkaz, Israel|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.